These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10677233)

  • 1. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion.
    Peisajovich SG; Epand RF; Epand RM; Shai Y
    Eur J Biochem; 2002 Sep; 269(17):4342-50. PubMed ID: 12199713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition.
    Ghosh JK; Peisajovich SG; Shai Y
    Biochemistry; 2000 Sep; 39(38):11581-92. PubMed ID: 10995225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses.
    Samuel O; Shai Y
    Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.
    Maddox MW; Longo ML
    Biophys J; 2002 Dec; 83(6):3088-96. PubMed ID: 12496080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178.
    Wexler-Cohen Y; Johnson BT; Puri A; Blumenthal R; Shai Y
    J Biol Chem; 2006 Apr; 281(14):9005-10. PubMed ID: 16455666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
    Pritsker M; Jones P; Blumenthal R; Shai Y
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion.
    Epand RF; Martin I; Ruysschaert JM; Epand RM
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1938-43. PubMed ID: 7811285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The helix-to-sheet transition of an HIV-1 fusion peptide derivative changes the mechanical properties of lipid bilayer membranes.
    Heller WT; Zolnierczuk PA
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):565-572. PubMed ID: 30550881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
    Ghosh JK; Shai Y
    J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
    Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
    J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides.
    Yang R; Yang J; Weliky DP
    Biochemistry; 2003 Apr; 42(12):3527-35. PubMed ID: 12653557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
    Slepushkin VA; Andreev SM; Sidorova MV; Melikyan GB; Grigoriev VB; Chumakov VM; Grinfeldt AE; Manukyan RA; Karamov EV
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):9-18. PubMed ID: 1736943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
    Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors contributing to the fusogenic potency of foamy virus.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 2001 Jun; 284(4):870-4. PubMed ID: 11409874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
    Suárez T; Nir S; Goñi FM; Saéz-Cirión A; Nieva JL
    FEBS Lett; 2000 Jul; 477(1-2):145-9. PubMed ID: 10899326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.